Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow

被引:3
|
作者
Patel, Shivani G. [1 ,2 ]
Husain, Nazia [1 ,2 ]
Rigsby, Cynthia K. [2 ,3 ,4 ]
Robinson, Joshua D. [1 ,2 ,4 ]
机构
[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Med Imaging, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
来源
CHILDREN-BASEL | 2022年 / 9卷 / 09期
关键词
pediatric; stress perfusion MRI; regadenoson; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RESERVE;
D O I
10.3390/children9091332
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Myocardial stress perfusion magnetic resonance imaging is a non-invasive tool to assess for myocardial ischemia and viability. Pediatric myocardial stress perfusion MRI can be challenging due to multiple intravenous lines, sedation, inadequate breath holding, fast heart rates, and complex anatomy. We performed a retrospective analysis in 39 children to evaluate safety and efficacy of regadenoson, a coronary vasodilator administered via a single intravenous line (6-10 mcg/kg), with respiratory motion correction (MOCO) and semi-quantitative blood flow analysis. Stress response data and adverse events were recorded, and image quality compared between native and MOCO reconstructions, assessing for perfusion deficits. Semi-quantitative analysis compared myocardial perfusion reserve index (MPRI) between patients who had a focal perfusion defect, patients who had undergone an orthotopic heart transplant, and non-transplant patients with no focal defects. Stress perfusion was completed in 38/39 patients (median age 15 years with a 41 +/- 27% rise in heart rate (p < 0.005). Fifteen out of thirty-eight had transient minor side effects with no major adverse events. MOCO image quality was better than non-MOCO (4.63 vs. 4.01 at rest, p < 0.005: 4.41 vs. 3.84 at stress, p < 0.005). Reversible perfusion defects were seen in 4/38 patients with lower segmental mean MPRI in the area of the perfusion defect, nearing statistical significance when compared to non-transplant patients with no defects (0.78 +/- 0.22 vs. 0.99 +/- 0.36, p = 0.07). The global MPRI of the 16 patients who had undergone orthotopic heart transplant was significantly lower than the non-transplant patients (0.75 +/- 0.22 vs. 0.92 +/- 0.23, p = 0.03). Regadenoson is a safe and effective coronary vasodilator for pediatric stress perfusion MRI with MOCO producing better image quality and allowing for semi-quantitative assessment of perfusion deficits that correlate with qualitative assessment.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Exercise Stress Perfusion Cardiac MRI in Pediatric Patients with Coronary Anomalies
    Carter, Elizabeth
    Moore, Rebecca
    Harris, Matthew
    Brothers, Julie
    CIRCULATION, 2024, 150
  • [32] Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging
    Lee, Daniel C.
    Johnson, Nils P.
    JACC-CARDIOVASCULAR IMAGING, 2009, 2 (06) : 761 - 770
  • [33] Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging
    Rafael Cabrera
    Zehra Husain
    Gurunanthan Palani
    Aarthee S. Karthikeyan
    Zain Choudhry
    Sunita Dhanalakota
    Ed. Peterson
    Karthik Ananthasubramaniam
    Journal of Nuclear Cardiology, 2013, 20 : 336 - 343
  • [34] Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification
    S. S. Koenders
    J. D. van Dijk
    P. L. Jager
    J. P. Ottervanger
    C. H. Slump
    J. A. van Dalen
    Journal of Nuclear Cardiology, 2019, 26 : 719 - 728
  • [35] Cardiac MRI assessment of myocardial perfusion
    Hamirani, Yasmin S.
    Kramer, Christopher M.
    FUTURE CARDIOLOGY, 2014, 10 (03) : 349 - 358
  • [36] Robust Myocardial Perfusion MRI Quantification With DeepFermi
    Brahma, Sherine
    Kofler, Andreas
    Zimmermann, Felix F.
    Schaeffter, Tobias
    Chiribiri, Amedeo
    Kolbitsch, Christoph
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2025, 72 (03) : 1031 - 1044
  • [37] Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification
    Koenders, S. S.
    van Dijk, J. D.
    Jager, P. L.
    Ottervanger, J. P.
    Slump, C. H.
    van Dalen, J. A.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (03) : 719 - 728
  • [38] Safety and Accuracy of Regadenoson Bolus Real Time Perfusion Stress Echocardiography
    Porter, Thomas R.
    Xie, Feng
    Adolphson, Mary
    O'Leary, Edward
    Olson, Joan
    Erdkamp, Michelle
    Therrien, Stacey L.
    Wong, Benjamin F.
    Eifert-Rain, Susan
    Abdelmoneim, Sahar S.
    Mulvagh, Sharon
    CIRCULATION, 2010, 122 (21)
  • [39] Feasibility and clinical efficacy of Regadenoson stress myocardial perfusion imaging as an alternative to Dobutamine in patients with obstructive Airway disease
    Panchadar, S.
    Biswas, G.
    Mohammad, M. H.
    Al-Ajmi, J.
    Al-Sayed, Y. M.
    Shukkur, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S200 - S200
  • [40] Quantification of myocardial blood flow with dynamic perfusion 3.0 Tesla MRI: Validation with 15o-water PET
    Tomiyama, Yuuki
    Manabe, Osamu
    Oyama-Manabe, Noriko
    Naya, Masanao
    Sugimori, Hiroyuki
    Hirata, Kenji
    Mori, Yuki
    Tsutsui, Hiroyuki
    Kudo, Kohsuke
    Tamaki, Nagara
    Katoh, Chietsugu
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 42 (03) : 754 - 762